Lundbeck
HLUN-B.CO
#2346
Rank
NZ$10.56 B
Marketcap
$10.92
Share price
0.98%
Change (1 day)
20.87%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Market capitalization of Lundbeck (HLUN-B.CO)

Market cap: NZ$10.56 Billion

As of September 2024 Lundbeck has a market cap of NZ$10.56 Billion. This makes Lundbeck the world's 2346th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lundbeck from 2005 to 2024

End of year Market Cap

Year Market cap Change
2024NZ$10.56 B42.03%
2023NZ$7.43 B30.67%
2022NZ$5.69 B467.61%
2021NZ$1.00 B-21.74%
2020NZ$1.28 B-14.78%
2019NZ$1.50 B-13.29%
2018NZ$1.73 B-8.83%
2017NZ$1.90 B21.49%
2016NZ$1.56 B17.39%
2015NZ$1.33 B97.86%
2014NZ$0.67 B-16.99%
2013NZ$0.81 B72.33%
2012NZ$0.47 B-44.3%
2011NZ$0.84 B30.83%
2010NZ$0.64 B-5.05%
2009NZ$0.68 B-34.71%
2008NZ$1.04 B10.11%
2007NZ$0.94 B-13.69%
2006NZ$1.09 B21.22%
2005NZ$0.90 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Lundbeck was reported to be:

NZ$10.56 Billion
by Yahoo Finance info icon info icon
NZ$10.56 Billion
by CompaniesMarketCap info icon info icon